Microseminoprotein-Beta Expression in Different Stages of Prostate Cancer.

Microseminoprotein-Beta Expression in Different Stages of Prostate Cancer.

Microseminoprotein-beta (MSMB, MSMB) is an abundant secretory protein contributed by the prostate, and is implicated as a prostate cancer (PC) biomarker based on observations of its lower expression in cancerous cells compared with benign prostate epithelium. However, as the current literature on MS...

Full description

Bibliographic Details
Main Authors:	Liisa Sjöblom, Outi Saramäki, Matti Annala, Katri Leinonen, Janika Nättinen, Teemu Tolonen, Tiina Wahlfors, Matti Nykter, G Steven Bova, Johanna Schleutker, Teuvo L J Tammela, Hans Lilja, Tapio Visakorpi
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2016-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4777373?pdf=render

Similar Items

Integrative proteomics in prostate cancer uncovers robustness against genomic and transcriptomic aberrations during disease progression
by: Leena Latonen, et al.
Published: (2018-03-01)

MiRNA Profiles in Lymphoblastoid Cell Lines of Finnish Prostate Cancer Families.
by: Daniel Fischer, et al.
Published: (2015-01-01)

Overall and worst gleason scores are equally good predictors of prostate cancer progression
by: Tuominen Vilppu J, et al.
Published: (2011-10-01)

Polymorphisms at the Microseminoprotein-beta locus associated with physiologic variation in beta-microseminoprotein and prostate-specific antigen levels.
by: Xu, X, et al.
Published: (2010)

NMD and microRNA expression profiling of the <it>HPCX1 </it>locus reveal <it>MAGEC1 </it>as a candidate prostate cancer predisposition gene
by: Tammela Teuvo LJ, et al.
Published: (2011-08-01)

Feature-based analysis of mouse prostatic intraepithelial neoplasia in histological tissue sections
by: Pekka Ruusuvuori, et al.
Published: (2016-01-01)

A linear model for transcription factor binding affinity prediction in protein binding microarrays.
by: Matti Annala, et al.
Published: (2011-01-01)

β-Microseminoprotein binds CRISP-3 in human seminal plasma
by: Udby, L, et al.
Published: (2005)

beta-Microseminoprotein binds CRISP-3 in human seminal plasma.
by: Udby, L, et al.
Published: (2005)

A common prostate cancer risk variant 5' of microseminoprotein-beta (MSMB) is a strong predictor of circulating beta-microseminoprotein (MSP) levels in multiple populations.
by: Waters, K, et al.
Published: (2010)

Clinical association analysis of ependymomas and pilocytic astrocytomas reveals elevated FGFR3 and FGFR1 expression in aggressive ependymomas
by: Birgitta Lehtinen, et al.
Published: (2017-05-01)

Beta-microseminoprotein in serum correlates with the levels in seminal plasma of young, healthy males.
by: Valtonen-André, C, et al.
Published: (2008)

Adaptive and non-adaptive gene expression responses in prostate cancer during androgen deprivation.
by: Reetta Nätkin, et al.
Published: (2023-01-01)

Adaptive and non-adaptive gene expression responses in prostate cancer during androgen deprivation
by: Reetta Nätkin, et al.
Published: (2023-01-01)

Levels of beta-microseminoprotein in blood and risk of prostate cancer in multiple populations.
by: Haiman, C, et al.
Published: (2013)

Cancer origin tracing and timing in two high-risk prostate cancers using multisample whole genome analysis: prospects for personalized medicine
by: Anssi Nurminen, et al.
Published: (2023-10-01)

Spatial analysis of histology in 3D: quantification and visualization of organ and tumor level tissue environment
by: Pekka Ruusuvuori, et al.
Published: (2022-01-01)

Assessing interactions of two loci (rs4242382 and rs10486567) in familial prostate cancer: statistical evaluation of epistasis.
by: Li-Sheng Chen, et al.
Published: (2014-01-01)

Association of cysteine-rich secretory protein 3 and beta-microseminoprotein with outcome after radical prostatectomy.
by: Bjartell, A, et al.
Published: (2007)

Correction: Microseminoprotein-Beta Expression in Different Stages of Prostate Cancer.
by: PLOS ONE Staff
Published: (2016-01-01)

Expression and ERG regulation of PIM kinases in prostate cancer
by: Sini K. Eerola, et al.
Published: (2021-05-01)

Leukemia prediction using sparse logistic regression.
by: Tapio Manninen, et al.
Published: (2013-01-01)

Expression of the miR-200 family in tumor tissue, plasma and urine of epithelial ovarian cancer patients in comparison to benign counterparts
by: Kalle Savolainen, et al.
Published: (2020-07-01)

The rs10993994 risk allele for prostate cancer results in clinically relevant changes in microseminoprotein-beta expression in tissue and urine.
by: Hayley C Whitaker, et al.
Published: (2010-10-01)

The Ubiquitin-Proteasome System Does Not Regulate the Degradation of Porcine β-Microseminoprotein during Sperm Capacitation
by: Lucie Tumova, et al.
Published: (2020-06-01)

The rs10993994 risk allele for prostate cancer results in clinically relevant changes in microseminoprotein-beta expression in tissue and urine
by: Whitaker, H, et al.
Published: (2010)

Design Framework and Principles for Learning Environment Co-Design: Synthesis from Literature and Three Empirical Studies
by: Tiina Mäkelä, et al.
Published: (2021-11-01)

ARLTS1 and prostate cancer risk--analysis of expression and regulation.
by: Sanna Siltanen, et al.
Published: (2013-01-01)

A simultaneous equation model to determine taper curve.
by: Kilkki, Pekka, et al.
Published: (1978-01-01)

The importance of LDL and cholesterol metabolism for prostate epithelial cell growth.
by: Teemu J Murtola, et al.
Published: (2012-01-01)

The role of plasma microseminoprotein-beta in prostate cancer: an observational nested case-control and Mendelian randomization study in the European prospective investigation into cancer and nutrition
by: Smith Byrne, K, et al.
Published: (2019)

Effects of composite casein and β-lactoglobulin genotypes on renneting properties and composition of bovine milk by assuming an animal model
by: Tiina Ikonen, et al.
Published: (1997-12-01)

Urinary prostate-specific antigen and microseminoprotein-beta levels in men with and without prostate cancer: A prospective cohort study
by: Prashant Shrivastava, et al.
Published: (2020-01-01)

Clinical Tear Fluid Proteomics—A Novel Tool in Glaucoma Research
by: Janika Nättinen, et al.
Published: (2022-07-01)

β-Microseminoprotein endows post coital seminal plasma with potent candidacidal activity by a calcium- and pH-dependent mechanism.
by: Anneli M L Edström Hägerwall, et al.
Published: (2012-01-01)

Balance between noise and information flow maximizes set complexity of network dynamics.
by: Tuomo Mäki-Marttunen, et al.
Published: (2013-01-01)

Combined Longitudinal Clinical and Autopsy Phenomic Assessment in Lethal Metastatic Prostate Cancer: Recommendations for Advancing Precision Medicine
by: Juho Jasu, et al.
Published: (2021-08-01)

Fanconi anemia pathway regulation by FANCI in prostate cancer
by: Heidi Kaljunen, et al.
Published: (2023-10-01)

Non-Steroidal Anti-Inflammatory Drugs and Cancer Death in the Finnish Prostate Cancer Screening Trial.
by: Thea Veitonmäki, et al.
Published: (2016-01-01)

Androgen Receptor Deregulation Drives Bromodomain-Mediated Chromatin Alterations in Prostate Cancer
by: Alfonso Urbanucci, et al.
Published: (2017-06-01)